Altria Group Inc (NYSE: MO) and Philip Morris International Inc (NYSE: PM) have entered into a contract manufacturing arrangement to enhance the operational efficiency of Philip Morris USA Inc’s traditional tobacco product operations.

The agreement leverages the respective capabilities of both entities in combustible cigarette manufacturing. Initial shipments under the arrangement are expected to begin in early 2027, subject to operational readiness and applicable regulatory requirements. Altria stated that it does not expect the deal to have a material impact on its 2026 financial results.

Strategic Context

The pact aims to support Altria’s 2028 Enterprise Goals by generating economic benefits and strengthening operating capabilities. These enhanced capabilities are transferable to Altria’s international nicotine initiatives. The company noted that the agreement should improve the efficiency of Philip Morris USA’s traditional tobacco operations while supporting broader strategic investments.

Altria emphasized that both entities will continue to operate independently. Each party retains full responsibility for its own commercialization, distribution, and regulatory activities. PMI confirmed it has not commercialized combustible cigarettes in the U.S. and has no plans to do so, a position unchanged by this manufacturing agreement.

Portfolio Overview

Altria’s wholly owned subsidiaries include Philip Morris USA Inc, the most profitable U.S. cigarette manufacturer, and John Middleton Co, a leading U.S. cigar manufacturer. Its smoke-free portfolio includes U.S. Smokeless Tobacco Company LLC, Helix Innovations LLC, and NJOY LLC.

Additionally, Altria holds a majority stake in Horizon Innovations LLC for heated tobacco stick marketing in the U.S. The company also maintains equity investments in Anheuser-Busch InBev SA/NV and Cronos Group Inc.

Market Reaction

Altria shares rose 3.87% to $68.65, while Philip Morris shares gained 2.60% to $193.12 on Monday. At $67.84 earlier in the session, Altria traded 3.4% above its 200-day simple moving average of $65.89, keeping the longer-term trend intact. However, shares remained 2.9% below the 50-day SMA of $70.16, indicating the intermediate trend has yet to fully recover. The stock’s relative strength index stood at 50.59, signaling neutral momentum.

Key resistance sits near $74, while support is around $63.50.

Analyst Outlook

Altria stock trades at a price-to-earnings multiple of 13.9 times. It carries a Hold consensus rating with an average price target of $70.

Barclays maintained an Underweight rating and lowered its price target to $58 on Aug. 11. Barclays previously raised its target to $64 on May 15 while maintaining an Underweight rating. UBS maintained a Buy rating and raised its target to $79 on July 7.

ETF Exposure

Significant inflows or outflows from funds with large Altria holdings can result in corresponding purchases or sales of shares. Key ETFs include:

Schall, Brown & Schwartz LLP announced an investigation into potential securities law violations by Altria Group, Inc. The probe follows the company’s July 30, 2026 report of second-quarter 2026 results and a subsequent full-year outlook reduction.

The investigation examines whether Altria issued false or misleading statements or failed to disclose material information to investors. The firm noted that the company’s decision to lower its full-year guidance caused its shares to fall.

Investigation Scope

Schall, Brown & Schwartz LLP is assessing claims on behalf of Altria shareholders who suffered losses during the relevant period. The review focuses on the accuracy and completeness of disclosures surrounding the Q2 2026 financial results and the revised outlook.

Shareholders interested in participating in the investigation may contact the firm directly. Brian Schall and David Schwartz can be reached at 310-301-3335 or via email at david@schallfirm.com . Additional details are available on the firm’s website.

Firm Background

Schall, Brown & Schwartz LLP specializes in securities class action lawsuits and shareholder rights litigation. The firm represents investors globally, leveraging the experience of founding partners Brian Schall, Andrew Brown, and David Schwartz to advocate for investor rights.

This press release may be considered attorney advertising in some jurisdictions under applicable laws and rules of ethics.